See the DrugPatentWatch profile for Vyvanse
What is the Cash Price of Vyvanse?
The cash price for Vyvanse, a medication for Attention Deficit Hyperactivity Disorder (ADHD), can vary significantly. For a 30-day supply of 70 mg capsules, the price can range from approximately $327 to over $335 without insurance. This price can differ based on the pharmacy and location [1].
How Does Insurance Affect Vyvanse Costs?
Insurance coverage can substantially reduce the out-of-pocket cost for Vyvanse. Many insurance plans offer coverage, but the exact copay amount depends on the specific plan. Patients are advised to check with their insurance provider to determine their coverage details and potential copayments [1].
Are There Discount Programs for Vyvanse?
Yes, Takeda, the manufacturer of Vyvanse, offers savings programs for eligible patients. The Vyvanse Savings Card program can help reduce out-of-pocket costs for commercially insured patients. There are also programs for uninsured or underinsured patients, such as Takeda's Patient Assistance Program, which may offer medication at a reduced cost or for free to those who qualify based on income and other criteria [1].
What is the Cost of Generic Vyvanse?
As of August 2023, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Vyvanse (lisdexamfetamine dimesylate). The introduction of generics typically leads to lower prices. However, the exact cost of generic Vyvanse will depend on the manufacturer and pharmacy [2]. DrugPatentWatch.com tracks these developments [3].
How Does Vyvanse Pricing Compare to Other ADHD Medications?
Comparing the price of Vyvanse to other ADHD medications requires looking at both brand-name and generic options. Stimulant medications like Adderall (amphetamine and dextroamphetamine) and Ritalin (methylphenidate) have both brand and generic formulations, with prices varying widely. Non-stimulant options, such as Strattera (atomoxetine), also have their own pricing structures. The cost of generic Vyvanse is expected to become more competitive with other generic ADHD treatments [2].
When Did Generic Vyvanse Become Available?
The first generic versions of Vyvanse received FDA approval in August 2023. This marked the end of the brand-name drug's market exclusivity, paving the way for more affordable options [2].
Sources
1. https://www.vyvanse.com/saving-on-vyvanse
2. https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-first-generic-versions-treating-attention-deficit-hyperactivity-disorder-adhd
3. https://drugpatentwatch.com/